GLP-1 receptor agonists for type 2 diabetes

[...] calcitonin screening in patients with thyroid nodules is associated with a high rate of false-positive results (eg, in case of renal failure, inflammation, H2-blockers, Zollinger-Ellison syndrome, and pernicious anaemia), and has a low positive predictive value (eg, for basal calcitonin

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2009-07, Vol.374 (9683), p.4-6
Main Authors: De Block, Christophe EM, Van Gaal, Luc F
Format: Article
Language:English
Subjects:
Blood pressure
Diabetes
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - epidemiology
Drugs
Glucagon-Like Peptide 1 - agonists
Glucagon-Like Peptide 1 - analogs & derivatives
Glucagon-Like Peptide 1 - therapeutic use
Humans
Hypoglycemic Agents - therapeutic use
Internal Medicine
Liraglutide
Mortality
Multicenter Studies as Topic
Neurons
Patients
Peptides - therapeutic use
Randomized Controlled Trials as Topic
Safety
Thyroid
Treatment Outcome
Tumors
Venoms - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...] calcitonin screening in patients with thyroid nodules is associated with a high rate of false-positive results (eg, in case of renal failure, inflammation, H2-blockers, Zollinger-Ellison syndrome, and pernicious anaemia), and has a low positive predictive value (eg, for basal calcitonin
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(09)60942-9